Lebanon, NH: The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) has awarded Celdara Medical a Fast-Track Small Business Innovation Research (SBIR) grant to fund the development of engineered regulatory T cells (Tregs) therapy for Amyotrophic Lateral Sclerosis (ALS). ALS is a debilitating […]
Celdara Medical seeks outstanding scientists with an interest in translational research and biotechnology for a paid Fellowship ($15/hour – remote optional). Prior Fellows have jumpstarted their careers in Venture Capital, Management Consulting, Technology Transfer, R&D, Medical Writing, and Business Development. Program Description 1-year experiential learning to gain real-world experience in biotechnology Develop executive skills including […]
Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to Celdara Medical. This award supports the ongoing development of CM-IAV1, a promising therapeutic antibody designed to treat high-priority influenzas that […]
Lebanon, NH: National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Technology Transfer (STTR) grant to fund the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome (HCPS). The funding will support the ongoing […]
Position Description Celdara Medical, LLC (CM) is building a portfolio of early-stage medical companies in collaboration with leading academicians. Each of these is at a different stage of development with a different development path. Celdara aims to bring these products to market with urgency. Our Mission is to give hope […]
Lebanon, NH: Celdara Medical, LLC announced today that participants in the inaugural DRIVEN Accelerator Hub Partner Program have collectively surpassed $100M in follow-on funding. Led by Celdara Medical and Simbex, and with seed funding from National Institute of General Medicine Sciences (NIGMS), the DRIVEN Accelerator Hub was established in 2018 […]
Celdara Medical, LLC today announced the awarding of six DRIVEN Accelerator Hub grants to outstanding researchers and innovators in the Northeast region. In this most recent round of funding, two Acceleration Awards (up to $50,000 per early-stage company) were awarded to Olfax Medical (Vermont) and ResusciTech (Rhode Island) and 4 Ignition Awards (up to $25,000 per faculty innovator) were awarded to Andre Khalil, PhD (University of Maine), Gian Ignacio, MD Candidate (Brown), Michael Cole, PhD (Dartmouth), and Yina Huang, PhD (Dartmouth).
Celdara Medical, LLC today announced the selection of five outstanding researchers as the recipients of the 2021 Celdara Medical High-Potential Entrepreneurs’ Fellowships (CHEF). The program provides a part-time, year-long experiential learning opportunity at Celdara to senior graduate students and post-doctoral researchers. Fellows receive an opportunity to hone their executive skills […]
Joana Murad Mabaera, Executive Director of R&D Expertise: Cellular Therapies and Molecular Biomarkers What are your professional interests & in what ways does Celdara help you engage those interests? My core professional interest is translational science. At Celdara Medical, I help build the foundation for the development of […]
ImmuType™ is a Celdara Medical Enterprise focused on providing improved care for patients with systemic autoimmune disease. By supporting patient stratification and identifying treatment responders based on each patient’s unique molecular profile, ImmuType™ can improve the success rate, while reducing time and cost of clinical trials. Beyond enrollment, ImmuType™ can […]